NF1 Loss Promotes EGFR Activation and Confers Sensitivity to EGFR Inhibition in NF1 Mutant Melanoma

Researchers utilized patient-derived short-term cultures and multiomics approaches to identify molecular features that could inform the development of therapies for patients with neurofibromin 1 (NF1) mutant melanoma.